Antiviral compounds

US9511056B2 · kind B2 · utility

Assignee

• Gilead Pharmasset LLC · US

Inventors

• Elizabeth M. Bacon · Burlingame, US
• Eda Canales · San Mateo, US
• Aesop Cho · Mountain View, US
• Jeromy J. Cottell · Redwood City, US
• Manoj C. Desai · Pleasant Hill, US
• Michael Graupe · Pacifica, US
• Hongyan Guo · San Mateo, US
• Randall L. Halcomb · Foster City, US
• Darryl Kato · Foster City, US
• Choung U. Kim · Redwood City, US
• Thorsten A. Kirschberg · Mountain View, US
• Evan S. Krygowski · Washington, US
• Scott E. Lazerwith · Foster City, US
• John O. Link · San Francisco, US
• Hongtao Liu · Cupertino, US
• Qi Liu · Beijing, CN
• Richard L. Mackman · Millbrae, US
• Michael L. Mitchell · Union City, US
• Jay P. Parrish · Cameron Park, US
• Hyung-Jung Pyun · Fremont, US
• Joseph H. Saugier · Foster City, US
• Scott D. Schroeder · Union City, US
• Jianyu Sun · Burnaby, CA
• James G. Taylor · Burlingame, US
• James D. Trenkle · Oakland, US
• Winston C. Tse · Redwood City, US
• Randall W. Vivian · San Mateo, US
• William J. Watkins · Saratoga, US
• Lianhong Xu · Durham, US

Key dates

• Filing date: May 16, 2014
• Grant date: Dec 6, 2016
• Expiry date: May 16, 2034

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07F5/025
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.